Home -> Law Blog Directory -> Patent Law Blogs -> Patently Obvious
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patently ObviousPriority Claims in Issued Patents
By Dennis Crouch, Esq.
Patent families continue to grow. With the increasing popularity provisional patent applications, most issued patents now claim priority to at least one prior patent filing. I created a database of all priority claims for non-reissue utility patents issued February 14, 2006 – February 17, 2009 (Pat. Nos. 7,000,000 – 7,493662). In fact, only 31% of the patents have no listed priority claims. For the graph below, I looked at the earliest listed priority date (one for each patent) and then categorized those according to the type of priority claim. 40% of the earliest claims were to foreign patent filings, and 18% claimed earliest priority to a provisional patent application. The remaining 11% earliest priorities reached back via US continuations, divisionals, and continuations-in-part (CIPs).
Full post as published by Patently Obvious on July 26, 2009 (boomark / email).
Paxil Lawsuit
Paxil Claims, Lawsuits, and Injuries
False Claims
Attorney Robert Arledge ordered to pay $5.8 million after making false Fen Phen settlement claims.
LINA - Cigna Life Insurance Company of North America Disability Claims
LINA Insurance alleging violations of disability insurance claims.
Nationwide Recall Issued for Certain Lots of Cleviprex
Nationwide Recall Issued for Certain Lots of Cleviprex
Class 1 Recall Issued for Penumbra Neuron 5F Select Catheter
Class 1 Recall Issued for Penumbra Neuron 5F Select Catheter>
Nationwide Recall Issued for Specific Lots of Atlas "Dietary Supplements"
Nationwide Recall Issued for Specific Lots of Atlas "Dietary Supplements"
Brave Log Splitters
New Recalls Issued

US Patent 7416699 - Nanotube interconnect between catalyst island contacts
83% Chance of Patent Term Extension Due to USPTO Delay
Geron comments on EPO/EBA decision on stem cell patent application
Round 2 - Part 3 Review of the New Continuation Rules
Which Two Masters Champions Have Been Issued Utility Patents since 1976
Restricted-Out Claims Not Eligible for Priority in Later CIP Application








